The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens
✅ Just Accepted
🔗 https://t.co/zeUNZQ0quq
This is summer time and we started fellows didactics with TBRD. Dr Cook has the best slides modified over past 25 years! @ECUHealth_ID. Welcome new fellows
Great Case Conference today by our fellow Dr. Rebecca Smidy and discussion by Dr. Hans Tillmann from @ECU_GI on acute Hepatitis B infection 🦠🔬 thanks for sharing your knowledge and experience with us! #hepatitis#hepatitisB#IDTwitter